Brain cancer immune therapy trial pulled before it started
Disease control
Terminated
This was a very early phase 1 trial that planned to test a personalized immune cell therapy for people with recurrent glioblastoma, an aggressive brain cancer. The treatment involved taking a patient's own T cells, activating them in a lab to target cancer stem cells, and giving …
Phase: PHASE1 • Sponsor: Jeremy Rudnick, M.D • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC